approval · primary record
EPTINEZUMAB-JJMR
FDA · BLA · 2026-06-05
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-06-05 |
| Brand | VYEPTI |
| Sponsor | Lundbeck Seattle BioPharmaceuticals, Inc. |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:11.114Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:EPTINEZUMAB-JJMR:2026-06-05
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.